These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1732009

  • 41. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ, Krikun G, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [Abstract] [Full Text] [Related]

  • 42. Sodium hyaluronate increases the fibrinolytic response of human peritoneal mesothelial cells exposed to tumor necrosis factor alpha.
    Reijnen MM, van Goor H, Falk P, Hedgren M, Holmdahl L.
    Arch Surg; 2001 Mar; 136(3):291-6. PubMed ID: 11231848
    [Abstract] [Full Text] [Related]

  • 43. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ, DeClerck YA, Laug WE.
    J Neurooncol; 1998 Dec; 40(3):215-26. PubMed ID: 10066093
    [Abstract] [Full Text] [Related]

  • 44. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, Blasi F.
    J Biol Chem; 1992 May 05; 267(13):9129-33. PubMed ID: 1315748
    [Abstract] [Full Text] [Related]

  • 45. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.
    van Hinsbergh VW, Vermeer M, Koolwijk P, Grimbergen J, Kooistra T.
    Blood; 1994 Nov 01; 84(9):2984-91. PubMed ID: 7949170
    [Abstract] [Full Text] [Related]

  • 46. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 01; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The plasminogen-activating system in hepatic stellate cells.
    Leyland H, Gentry J, Arthur MJ, Benyon RC.
    Hepatology; 1996 Nov 01; 24(5):1172-8. PubMed ID: 8903394
    [Abstract] [Full Text] [Related]

  • 49. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH.
    J Cell Biol; 1991 Oct 01; 115(1):191-9. PubMed ID: 1918136
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
    Tanabe T.
    Hiroshima J Med Sci; 2000 Mar 01; 49(1):67-72. PubMed ID: 10824459
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Alpha- and gamma-interferon inhibit plasminogen activator inhibitor-1 gene expression in human retinal pigment epithelial cells.
    Sirén V, Immonen I, Cantell K, Vaheri A.
    Ophthalmic Res; 1994 Mar 01; 26(1):1-7. PubMed ID: 8134084
    [Abstract] [Full Text] [Related]

  • 54. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
    Wang W, Chen HJ, Giedd KN, Schwartz A, Cannon PJ, Rabbani LE.
    Circ Res; 1995 Dec 01; 77(6):1095-106. PubMed ID: 7586221
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD.
    Exp Cell Res; 1996 Mar 15; 223(2):395-404. PubMed ID: 8601416
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct 15; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 60. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    Estreicher A, Mühlhauser J, Carpentier JL, Orci L, Vassalli JD.
    J Cell Biol; 1990 Aug 15; 111(2):783-92. PubMed ID: 2166055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.